These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 13868525)

  • 1. [Use and indications of an antidepressant P 1133, nialamide (Niamide)].
    BERTRAND V; BENOIT JC; DAVID A
    Ann Med Psychol (Paris); 1961 Jul; 119(2)():333-7. PubMed ID: 13868525
    [No Abstract]   [Full Text] [Related]  

  • 2. [The use of nialamide in some depression states].
    ROSA J
    Dia Med; 1961 Feb; 33():131-2. PubMed ID: 13743226
    [No Abstract]   [Full Text] [Related]  

  • 3. [Efficacy of nialamide in states of depression].
    GUILLERM H; DAVOST PH; GRANDMONTAGE O; PRUD'HOMME B
    Ann Med Psychol (Paris); 1960 May; 118(1)():972-8. PubMed ID: 13830184
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of nialamide alone and in combination in treatment of depression.
    PARKER S
    Dis Nerv Syst; 1959 Dec; 20():591-3. PubMed ID: 14430509
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy and safety of nialamide in the treatment of depressive syndromes.
    KRAKOWSKI AJ
    Dis Nerv Syst; 1961 Mar; 22():167-71. PubMed ID: 13753904
    [No Abstract]   [Full Text] [Related]  

  • 6. An objective assessment of the effects of nialamide on depressed patients.
    INGLIS J; CAIRD WK; SLOANE RB
    Can Med Assoc J; 1961 May; 84(19):1059-63. PubMed ID: 13717702
    [No Abstract]   [Full Text] [Related]  

  • 7. [Nialamide in the treatment of schizophrenic depression and of dipsomania].
    OROZCO W
    Rev Asoc Medica Mex; 1960 Mar; 40():132-41. PubMed ID: 14429109
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of depressive states and chronic alcoholism with nialamide].
    ROSA JJ
    Prensa Med Argent; 1961 Apr; 48():891-6. PubMed ID: 14493774
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of endogenous depressions by a new inhibitor of monoamine oxidase: nialamide].
    VAN REETH PC; BLOCH C
    Acta Neurol Psychiatr Belg; 1960 Mar; 60():320-7. PubMed ID: 13841128
    [No Abstract]   [Full Text] [Related]  

  • 10. Behavioral evaluation of imipramine and nialamide in regressed schizophrenic patients with depressive features.
    LEUTHOLD CA; BRADSHAW FJ; ARNDT GW; HOFFMAN EF; PISHKIN V
    Am J Psychiatry; 1961 Oct; 118():354-5. PubMed ID: 14464450
    [No Abstract]   [Full Text] [Related]  

  • 11. Psychological effects of isocarboxazid and nialamide on a group of depressed patients.
    VASSILIOU V; HIMWICH HE
    J Clin Psychol; 1961 Jul; 17():319-20. PubMed ID: 13780453
    [No Abstract]   [Full Text] [Related]  

  • 12. CPT and VCRT performances as functions of imipramine and nialamide.
    PISHKIN V
    J Clin Psychol; 1962 Jan; 18():83-6. PubMed ID: 14486949
    [No Abstract]   [Full Text] [Related]  

  • 13. A clinical and biochemical study of monoamine oxidase inhibition in depressed patients. I. A clinical trial of Nialamide.
    DEWHURST WG; PARE CM
    J Ment Sci; 1961 Mar; 107():239-43. PubMed ID: 13722403
    [No Abstract]   [Full Text] [Related]  

  • 14. A clinical and biochemical study of monoamine oxidase inhibition in depressed patients. II. 5-Hydroxytryptamine tolerance before and after Nialamide.
    DEWHURST WG; PARE CM
    J Ment Sci; 1961 Mar; 107():244-9. PubMed ID: 13722404
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical results of the use of nialamide in depressive states].
    ROTONDI A; GIACANELLI F; CORNELI R
    Minerva Med; 1960 Jul; 51():2580-3. PubMed ID: 13743919
    [No Abstract]   [Full Text] [Related]  

  • 16. [CRITICAL CONSIDERATIONS ON THE PHARMACOTHERAPY OF DEPRESSION].
    VENCOVSKY E
    Cesk Psychiatr; 1963 Jun; 59():151-8. PubMed ID: 14081805
    [No Abstract]   [Full Text] [Related]  

  • 17. Differentiation of two genetically specific types of depression by the response to anti-depressants.
    PARE CM; REES L; SAINSBURY MJ
    Lancet; 1962 Dec; 2(7270):1340-3. PubMed ID: 13941389
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacological studies with nialamide, a new antidepressant agent.
    ROWE RP; BLOOM BM; PAN SY; FINGER KF
    Proc Soc Exp Biol Med; 1959; 101():832-6. PubMed ID: 14439694
    [No Abstract]   [Full Text] [Related]  

  • 19. [Metabolic craneopathy and antidepressive therapeutics. (Neuroendocrine endocranial hyperostotic syndrome (N.E.H.S.) or Morgagni-Stewart-Morel-Pende syndrome and nialamide].
    FLOREZ TASCON FJ
    Rev Clin Esp; 1960 Mar; 76():357-72. PubMed ID: 13823576
    [No Abstract]   [Full Text] [Related]  

  • 20. [Trial of niamide in schizophrenia and depressive states].
    GARDE S; LE MOAL ; BRISOU
    J Med Bord; 1961 Jul; 138():911-3. PubMed ID: 13703586
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.